Medicinal products for human and investigational use / Derogations - Timeline

Adottati on 23/02/2022 - Bureau decision date: 18/01/2022

Riferimento:

INT/975-EESC-2022-2022-00378

Opinion Type:

Obbligatoria

Referral:

Rapporteur:

Martin SCHAFFENRATH (Diversity Europe - GR III / Austria)

Sessione plenaria:

567 -

Feb 23, 2022 Feb 24, 2022

23Feb2022

Medicinali per uso umano e per uso sperimentale/Deroghe

Type:

Committee opinion (PAC)

ALTO CONTRASTO